At #ACC24 , DCRI’s Pamela S Douglas joined Healio to discuss the new Project REACH initiative, which seeks to increase diversity and equity in clinical trial leadership. Watch her video interview here to learn more: healio.com/news/cardiolog…

In a new review for JACC Journals, DCRI Fellow Mark Kittipibul MD and Robert Mentz, MD discuss the benefits of SGLT2i, the associated risk of GU infections, and practice considerations for patients with cardiovascular disease: sciencedirect.com/science/articl…

The DCRI is excited to partner with Saghmos Therapeutics to optimize and plan the operationalization of their Phase 3 study for its cardio-renal metabolic modulator ST-62516. Learn more here: dcri.org/news/saghmos-t…

What is the future of moving #evidencebased therapies into action for #CKM disease? Broad #dissemination of results and training the next generation of #knowledgetranslation scientists. Be a part of the #ImpSci conversation. #CVD Read more: duke.is/imp-summit

DCRI faculty & fellows shared new insights and expertise on the latest in cardiology research as part of the over 100 late-breaking studies, presentations, panels, and posters at #ACC24 . Get caught up on some of the top stories from the event here: dcri.org/news/acc-2024-…

Several heart conditions like HOCM can be inherited – yet many are unaware of their family’s heart health history. DCRI’s Svati Shah shares helpful tips on to talk to your family about heart health, including what questions to ask and who to talk to: time.com/6965727/how-to…

A newly-published paper featuring DCRI authors Nishant Shah, MD, Neha Pagidipati, and Svati Shah explores how comprehensive health parameter associate with BMI, offering a deeper understanding of cardiovascular health across BMI. pubmed.ncbi.nlm.nih.gov/38550633/

Hospital costs for those with #HFrEF tend to be high – yet the factors that contribute to these costs vary. DCRI Fellow Mark Kittipibul MD sat down with HCPLive at #ACC24 to discuss the GWTG-HF registry, and how to reduce HF-related costs: hcplive.com/view/understan…

That wraps up #ACC24 ! Stayed tuned for our event recap, where we’ll cover the great findings shared by those at the DCRI.

DCRI's Robert Mentz, MD's focus on 'beans' at #ACC24 highlighted how GDMT, including RAASi and SGLT2, can potentially reduce CV and renal events and lead to fewer discontinuations of other therapies. For patients with CKD, GDMT, this may result in an even greater benefit.

Shelby Reed’s presentation on the health economics of lipid-lowering medications will begin in 15 minutes at #ACC24 .

DCRI’s Larry Jackson will present and serving as a panelist at the #ACC24 session “Sharing the Sandbox: The Importance of Collaboration Between EP and HF” in 15 minutes.

DCRI's Jennifer Rymer and Schuyler Jones, along with former DCRI member Sunil V. Rao, took a deep dive into the ACS toolbox at #ACC24 today, where they examined guidelines, proven and potential therapies, and opportunities to tailor approaches to each patient's unique needs.

DCRI Fellows Nina Nouhravesh & Satoshi Shoji earlier today at #ACC24 : Nina discussed the benefits of a Sacubitril/Valsartan treatment plan for HFrEF patients, while Satoshi covered insights from CONNECT-HF on how to better follow up with remote heart failure patients.

In 15 minutes, DCRI’s Robert Mentz, MD will join other #ACC24 experts to share insights regarding how HF GDMT reduces renal events with long-term renal protection and cardio-renal benefits.

DCRI fellow Nina Nouravesh shares findings from a HEART-FID examining hypophosphatemia associated with ferric carboxymaltose in 15 minutes at #ACC24

In 15 minutes at #ACC24 , Marat Fudim, MD MHS addresses findings related to unintentional underdosing in anemic patients receiving IV infusions.

“In this post-hoc on-treatment analysis of TRANSFORM-HF — inclusive of all randomized patients, unless they were confirmed to be non-adherent — there was no significant difference in outcomes between torsemide and furosemide,” said DCRI Fellow Mark Kittipibul MD at #ACC24 .

Visit DCRI fellow Satoshi Shoji at #ACC24 for a poster presentation on why integrating centralized call centers and medical record queries for remote follow-up may reduce rates of missed hospitalization events and better capture clinical outcomes.

DCRI fellow Nina Nouravesh will present findings from a subgroup analysis of PARAGLIDE-HF focused on sacubitril/valsartan initiation in 15 minutes at #ACC24 .